UNITED
STATES
SECURITIES
AND
EXCHANGE
COMMISSION
Washington,
D.C.
20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report
(Date
of
earliest
event
Reported):
November 3, 2020
Amphastar
Pharmaceuticals,
Inc.
(Exact
Name
of
Registrant
as
Specified
in
Charter)
|
|
|
Delaware
|
001-36509
|
33-0702205
|
(State
or
Other
Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
Number)
|
|
|
11570
6th
Street
|
|
Rancho
Cucamonga,
California
|
91730
|
(Address
of Principal
Executive
Offices)
|
(Zip
Code)
|
Registrant's
telephone
number,
including
area
code:
(909)
980-9484
Not
Applicable
(Former
name
or
former
address,
if
changed
since
last
report)
Check
the
appropriate
box
below
if
the
Form
8-K
filing
is
intended
to simultaneously
satisfy
the
filing
obligation
of the
registrant
under
any
of the
following provisions:
☐Written
communications
pursuant
to
Rule
425
under
the
Securities
Act
(17
CFR
230.425)
☐Soliciting
material
pursuant
to
Rule
14a-12
under
the
Exchange
Act
(17
CFR
240.14a-12)
☐Pre-commencement
communications
pursuant
to
Rule
14d-2(b)
under
the
Exchange
Act
(17
CFR
240.14d-2(b))
☐Pre-commencement
communications
pursuant
to
Rule
13e-4(c)
under
the
Exchange
Act
(17
CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name of
each exchange on which registered
|
|
|
|
|
Common
Stock, par value $0.0001 per share
|
|
AMPH
|
|
The
NASDAQ
Stock
Market LLC
|
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2
of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
☐